• OPEN AN ACCOUNT
Indian Indices
Sensex
74,781.76 -120.83
( -0.16%)
Global Indices
Nasdaq
52,596.82 511.72
(0.98%)
Dow Jones
7,678.62 65.92
(0.87%)
Hang Seng
63,979.83 -1,291.12
(-1.98%)
Nikkei 225
10,650.44 41.52
(0.39%)
Forex
USD-INR
95.45 0.39
(0.41%)
EUR-INR
110.95 0.35
(0.32%)
GBP-INR
129.16 0.36
(0.28%)
JPY-INR
0.62 0.00
(0.09%)

EQUITY - MARKET SCREENER

Mastek Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
523704
INE759A01021
279.8918481
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MASTEK
23.85
5043.34
EPS(TTM)
Face Value()
Div & Yield %
68.2
5
0.98
 

a b infrabuild ltd
Fredun forays into pet wellness with acquisition of Furlicks
Sep 08,2026

Fredun Pharmaceuticals (FPL) has acquired Furlicks, an innovative pet-wellness brand focused on convenient, easy-to-administer oral-strip solutions for pets. The acquisition of Furlicks from USV & Wellbeing Nutrition brings the brand's differentiated product innovation and consumer understanding into the FPL Group.

Speaking on the acquisition, Fredun Medhora, MD & CFO, Fredun Pharmaceuticals stated, “Furlicks marks a bold new chapter in FPL's journey into pet wellness. We see Furlicks as more than an addition to our portfolio- it is a differentiated platform with the potential to build a significant pet-wellness business. By combining Furlicks' innovation and consumer-first approach with FPL's manufacturing capabilities, scale and execution strength, we aim to make quality pet care more accessible to millions of pet parents across India. Our focus is to scale Furlicks while preserving what makes the brand special: its innovation, simplicity and deep understanding of pet parents. With FPL's resources and capabilities behind it, we see a strong opportunity to take what Furlicks has built to the next level and create India's first comprehensive pet-wellness platform.”

The immediate focus for FPL will be on scaling the existing business by introducing 12 new SKUs in the 1st phase, with 32 new SKUs aligned for launch in the second phase.